Related Experiment Videos
Beta(+)-thalassemia with hemochromatosis
M Uchihara1, T Nouchi, T Harano
1Department of Internal Medicine, Hokushin General Hospital, Nagano, Japan.
Internal Medicine (Tokyo, Japan)
|August 1, 1992
Summary
This study identifies a novel beta-globin gene mutation causing beta-thalassemia in a patient with hemochromatosis. Genetic analysis confirmed the homozygous mutation and heterozygous carriers in his offspring.
Area of Science:
- Genetics
- Hematology
- Molecular Biology
Background:
- Beta-thalassemia is a genetic blood disorder characterized by reduced or absent beta-globin synthesis.
- Hemochromatosis is a condition of iron overload, often affecting the liver.
Observation:
- A 64-year-old male presented with ascites and laboratory findings suggestive of anemia and iron overload.
- Liver biopsy confirmed hemochromatosis, while in vitro globin synthesis ratio indicated beta-thalassemia.
Findings:
- Genetic analysis revealed a specific A-to-G mutation in the ATA box of the beta-globin gene.
- The patient was homozygous for this mutation, confirmed by gene complex and Southern blot analyses.
- His two sons were identified as heterozygous carriers of the identified allele.
Implications:
- This finding elucidates a novel genetic cause for beta-thalassemia.
- Understanding this mutation aids in diagnosing and managing patients with combined hemochromatosis and thalassemia.
- Genetic counseling and carrier screening are important for affected families.